Video: Elevated Homocysteine in Parkinson’s

Scientific literature contains a multitude of research studies linking homocysteine to poor health. Elevated homocysteine in Parkinson’s is thought to worsen oxidative stress on the neurons that produce dopamine and make them more easily damaged by environmental toxins. This video by Neurology Solutions Nurse Practitioner Jordan Harborth explains the correlation between homocysteine (Hcy), a non-protein amino acid, and neurological conditions such as Parkinson’s and Alzheimer’s disease.

metabolic enhancement for neurodegeneration

Metabolic Enhancement for NeuroDegeneration shows promise

Researchers say Metabolic Enhancement for NeuroDegeneration (MEND)−a combination therapy to slow neurodegeneration−may partially reverse and stabilize cognitive decline. Participants with mild cognitive decline and Alzheimer’s style dementia who took part in a two-year MEND study demonstrated real, life-altering improvements after following the MEND protocol for 5 to 24 months, the study showed.

The MEND program calls for interventions to treat conditions such as inflammation, stress and diabetes that could be associated with Alzheimer’s and dementia. It involves multiple components including dietary adjustments, exercise, stress reduction, hormone balance, sleep optimization and integration of certain vitamins and supplements to the patient’s regular routine.

© 2024 Neurology Solutions. All Rights Reserved.